JP2023553702A5 - - Google Patents

Info

Publication number
JP2023553702A5
JP2023553702A5 JP2023536888A JP2023536888A JP2023553702A5 JP 2023553702 A5 JP2023553702 A5 JP 2023553702A5 JP 2023536888 A JP2023536888 A JP 2023536888A JP 2023536888 A JP2023536888 A JP 2023536888A JP 2023553702 A5 JP2023553702 A5 JP 2023553702A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
tnf antibody
composition according
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023536888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023553702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/061863 external-priority patent/WO2022130281A1/en
Publication of JP2023553702A publication Critical patent/JP2023553702A/ja
Publication of JP2023553702A5 publication Critical patent/JP2023553702A5/ja
Pending legal-status Critical Current

Links

JP2023536888A 2020-12-17 2021-12-16 活動性強直性脊椎炎を処置するための抗ｔｎｆ抗体、組成物及び方法 Pending JP2023553702A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063126638P 2020-12-17 2020-12-17
US63/126,638 2020-12-17
US202163140307P 2021-01-22 2021-01-22
US63/140,307 2021-01-22
PCT/IB2021/061863 WO2022130281A1 (en) 2020-12-17 2021-12-16 Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis

Publications (2)

Publication Number Publication Date
JP2023553702A JP2023553702A (ja) 2023-12-25
JP2023553702A5 true JP2023553702A5 (https=) 2024-12-25

Family

ID=82022069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536888A Pending JP2023553702A (ja) 2020-12-17 2021-12-16 活動性強直性脊椎炎を処置するための抗ｔｎｆ抗体、組成物及び方法

Country Status (9)

Country Link
US (1) US20220195028A1 (https=)
EP (1) EP4262869A4 (https=)
JP (1) JP2023553702A (https=)
KR (1) KR20230121110A (https=)
AU (1) AU2021399266A1 (https=)
CA (1) CA3205027A1 (https=)
IL (1) IL303725A (https=)
MX (1) MX2023007296A (https=)
WO (1) WO2022130281A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110251099A1 (en) * 2008-12-30 2011-10-13 Sudha Visvanathan SERUM MARKERS PREDICTING CLINICAL RESPONSE TO ANTI-TNFa ANTIBODIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
MX2019009377A (es) * 2017-02-07 2019-12-11 Janssen Biotech Inc Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la espondilitis anquilosante activa.
JP7805788B2 (ja) * 2019-05-23 2026-01-26 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
MX2021014882A (es) * 2019-06-03 2022-03-25 Janssen Biotech Inc Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
IL298389A (en) * 2020-05-21 2023-01-01 Janssen Biotech Inc Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Similar Documents

Publication Publication Date Title
TWI477273B (zh) 低頻率格拉替雷（ｇｌａｔｉｒａｍｅｒ）醋酸鹽之治療
TW202323296A (zh) 組合療法
JP2025172841A5 (https=)
JP2022543612A5 (https=)
BR112021008778A2 (pt) Métodos de tratamento da oftalmopatia de graves usando anticorpos anti-fcrn
JP2018511609A5 (https=)
AU2021319090A1 (en) Treatment of migraine
JP2024531151A5 (https=)
JP2020100653A (ja) ベンラリツマブによる喘息症状の改善方法
JP2019507775A5 (https=)
JP2025502095A5 (https=)
JP2024532263A5 (https=)
JP2024531314A (ja) 小児ｍｓを治療するためのオファツムマブ
JP2021532176A5 (https=)
JP2025501239A5 (https=)
JP2022514561A5 (https=)
JP2021522241A5 (https=)
JP2023553702A5 (https=)
JP2022534494A5 (https=)
JP2023544620A5 (https=)
HOWARD et al. Effects of pituitary adrenocorticotropic hormone (ACTH) on the hypersensitive state
JP2005529152A5 (https=)
JP2022527542A5 (https=)
JP2022526493A5 (https=)
JP2024526742A5 (https=)